Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study
Research Synthesis Methods · 2024
DOI: 10.1002/jrsm.1708 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Research Synthesis Methods, 2024. Verfasst von Silja H Overgaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Molecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University of Southern Denmark, Denmark. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Oak Foundation, Knud og Edith Eriksens Mindefond, Region Syddanmark.
Abstract (Originalsprache)
The objective of this meta‐epidemiological study was to explore the impact of attrition rates on treatment effect estimates in randomised trials of chronic inflammatory diseases (CID) treated with biological and targeted synthetic disease‐modifying drugs. We sampled trials from Cochrane reviews. Attrition rates and primary endpoint results were retrieved from trial publications; Odds ratios (ORs) were calculated from the odds of withdrawing in the experimental intervention compared to the control comparison groups (i.e., differential attrition), as well as the odds of achieving a clinical response (i.e., the trial outcome). Trials were combined using random effects restricted maximum likelihood meta‐regression models and associations between estimates of treatment effects and attrition rates were analysed. From 37 meta‐analyses, 179 trials were included, and 163 were analysed (301 randomised comparisons; n = 62,220 patients). Overall, the odds of withdrawal were lower in the experimental compared to control groups (random effects summary OR = 0.45, 95% CI, 0.41–0.50). The corresponding overall treatment effects were large (random effects summary OR = 4.43, 95% CI 3.92–4.99) with considerable heterogeneity across interventions and clinical specialties ( I 2 = 85.7%). The ORs estimating treatment effect showed larger treatment benefits when the differential attrition was more prominent with more attrition in the control group (OR = 0.73, 95% CI 0.55–0.96). Higher attrition rates from the control arm are associated with larger estimated benefits of treatments with biological or targeted synthetic disease‐modifying drugs in CID trials; differential attrition may affect estimates of treatment benefit in randomised trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Molecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University of Southern Denmark, Denmark.
- Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
- Department of Internal Medicine, University Hospital of Southern Denmark, Aabenraa, Denmark.
- Department of Clinical Research, University Hospital of Southern Denmark, Aabenraa, Denmark.
- Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA.
- Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Silja H Overgaard, Caroline M Moos, John P A Ioannidis, George Luta, Sabrina M Nielsen, Vibeke Andersen, Robin Christensen
Förderung
- Oak Foundation
- Knud og Edith Eriksens Mindefond
- Region Syddanmark
Zitieren
APA
Overgaard, S. H., Moos, C. M., Ioannidis, J. P. A., Luta, G., Berg, J. I., Nielsen, S. M., Andersen, V., & Christensen, R. (2024). Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study. Research Synthesis Methods. https://doi.org/10.1002/jrsm.1708
Vancouver
Overgaard SH, Moos CM, Ioannidis JPA, Luta G, Berg JI, Nielsen SM, et al. Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study. Research Synthesis Methods. 2024. doi:10.1002/jrsm.1708
BibTeX
@article{Overgaard2024,
author = {Overgaard, Silja H and Moos, Caroline M and Ioannidis, John P A and Luta, George and Berg, Johannes I and Nielsen, Sabrina M and Andersen, Vibeke and Christensen, Robin},
title = {Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study},
journal = {Research Synthesis Methods},
year = {2024},
doi = {10.1002/jrsm.1708}
}
EUVIMED